BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 12160898)

  • 1. Chemical models for cytochrome P450 as a biomimetic metabolic activation system in mutation assays.
    Inami K; Mochizuki M
    Mutat Res; 2002 Aug; 519(1-2):133-40. PubMed ID: 12160898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of mutagenicity in Ames test using a metalloporphyrin/oxidant model system for cytochrome P450.
    Okochi E; Kurahashi A; Mochizuki M
    Mutat Res; 1997 Jan; 373(1):99-105. PubMed ID: 9015158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of N-nitrosodialkylamines to mutagens by a metalloporphyrin/oxidant model system for cytochrome P450.
    Okochi E; Namai E; Ito K; Mochizuki M
    Biol Pharm Bull; 1995 Jan; 18(1):49-52. PubMed ID: 7735249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenicity of aromatic amines and amides with chemical models for cytochrome P450 in Ames assay.
    Inami K; Okazawa M; Mochizuki M
    Toxicol In Vitro; 2009 Sep; 23(6):986-91. PubMed ID: 19563884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative transformation of 2-acetylaminofluorene by a chemical model for cytochrome P450: A water-insoluble porphyrin and tert-butyl hydroperoxide.
    Inami K; Mochizuki M
    Bioorg Med Chem; 2008 Jul; 16(14):7070-7. PubMed ID: 18586499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dealkylation of N-nitrosodibenzylamine by metalloporphyrin/oxidant model systems for cytochrome P450.
    Okochi E; Mochizuki M
    Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2173-6. PubMed ID: 8582020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of promutagens by porphyrinic biomimetic systems.
    Rueff J; Rodrigues A; Laires A; Gaspar J
    Mutat Res; 1992 Oct; 269(2):243-50. PubMed ID: 1383708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of aromatic amine mutagenicity in Salmonella typhimurium with rat-liver 9000 g supernatant or monolayers of rat hepatocytes as an activation system.
    Holme JA; Haug LT; Dybing E
    Mutat Res; 1983 Apr; 117(1-2):113-25. PubMed ID: 6339903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of ten strains of genetically engineered Salmonella typhimurium TA1538 each co-expressing a form of human cytochrome P450 with NADPH-cytochrome P450 reductase sensitive to various promutagens.
    Yamazaki Y; Fujita K; Nakayama K; Suzuki A; Nakamura K; Yamazaki H; Kamataki T
    Mutat Res; 2004 Aug; 562(1-2):151-62. PubMed ID: 15279838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of three different in vitro mutation assays used for the investigation of cytochrome P450-mediated mutagenicity of nitro-polycyclic aromatic hydrocarbons.
    Kappers WA; van Och FM; de Groene EM; Horbach GJ
    Mutat Res; 2000 Mar; 466(2):143-59. PubMed ID: 10727902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cigarette smoke on the mutagenic activation of various carcinogens in hamster.
    Mori Y; Iimura K; Furukawa F; Nishikawa A; Takahashi M; Konishi Y
    Mutat Res; 1995 Jan; 346(1):1-8. PubMed ID: 7530323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of rat lymphocyte activation of benzo[a]pyrene, 2-acetylaminofluorene, and several of their metabolites to mutagenic and DNA-damaging species in vitro.
    Gao N; Aidoo A; Heflich RH
    Teratog Carcinog Mutagen; 1991; 11(2):65-76. PubMed ID: 1686675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic activation of heterocyclic amines and other procarcinogens in Salmonella typhimurium umu tester strains expressing human cytochrome P4501A1, 1A2, 1B1, 2C9, 2D6, 2E1, and 3A4 and human NADPH-P450 reductase and bacterial O-acetyltransferase.
    Oda Y; Aryal P; Terashita T; Gillam EM; Guengerich FP; Shimada T
    Mutat Res; 2001 May; 492(1-2):81-90. PubMed ID: 11377247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of promutagenic chemicals by Streptomyces griseus containing cytochrome P-450soy.
    Sariaslani FS; Stahl RG
    Biochem Biophys Res Commun; 1990 Jan; 166(2):743-9. PubMed ID: 2105727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of polycyclic aromatic hydrocarbon metabolites from a peroxynitrite/iron(III) porphyrin biomimetic model and their mutagenicities.
    Luo Y; Dai J; Zhong R; She Y; Liu R; Wei H
    Environ Toxicol Chem; 2011 Mar; 30(3):723-9. PubMed ID: 21298714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purified prostaglandin synthase activates aromatic amines to derivatives that are mutagenic to Salmonella typhimurium.
    Sarkar FH; Radcliff G; Callewaert DM
    Mutat Res; 1992 Aug; 282(4):273-81. PubMed ID: 1379690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of 2-aminofluorene in the mutagenic activation of 2-acetylaminofluorene.
    Robertson IG
    Mutat Res; 1986 Nov; 175(3):153-7. PubMed ID: 3534560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic activation of chemical carcinogens by hepatic preparations from streptozotocin-treated rats.
    Flatt PR; Bass SL; Ayrton AD; Trinick J; Ioannides C
    Diabetologia; 1989 Feb; 32(2):135-9. PubMed ID: 2524416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Escherichia coli DJ4309 expressing human P450 1A2 in mutagenicity testing of complex food mixtures.
    Constable A; Varga N; Josephy PD; Guy P; Turesky RJ
    Mutat Res; 1999 Jun; 442(2):79-87. PubMed ID: 10393276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cigarette smoke on the mutagenic activation of environmental carcinogens by rodent liver.
    Koide A; Fuwa K; Furukawa F; Hirose M; Nishikawa A; Mori Y
    Mutat Res; 1999 Jul; 428(1-2):165-76. PubMed ID: 10517990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.